Literature DB >> 22257982

Changes in baroreflex control of renal sympathetic nerve activity in high-fat-fed rats as a predictor of hypertension.

Núbia M Fardin1, Lila M Oyama, Ruy R Campos.   

Abstract

There is evidence that obesity is associated with increased sympathetic activity and hypertension. However, the mechanisms responsible for these changes are not fully understood. Therefore, the aim of the present study was to evaluate the cardiovascular function and the baroreceptor reflex control of renal sympathetic nerve activity (rSNA) in rats exposed to a high-fat diet over different periods (10 and 20 weeks) compared to control rats. Serum leptin levels were assessed for all time points. Male Wistar rats weighing 150-180 g were used. Four groups of rats were studied: control 10 weeks (Ct10), obese 10 weeks (Ob10), control 20 weeks (Ct20), and obese 20 weeks (Ob20). Blood pressure (BP) and rSNA were recorded in urethane-anesthetized rats (1.4 g/kg, intravenous).The sensitivity of rSNA responses to baroreceptor reflex was assessed by changes in BP induced by increasing doses of phenylephrine or sodium nitroprusside. Significant and progressive increases in serum leptin levels were found in the obese rats, but not in the control rats. No changes in basal BP or rSNA were found in the Ob10 and Ob20 groups; however, a significant impairment in the baroreceptor sensitivity was observed in the Ob20 group for phenylephrine (slope Ob20: -0.78 ± 0.12 vs. Ct20: -1.00 ± 0.08 potential per second (pps)/mm Hg, P < 0.05) and sodium nitroprusside (slope Ob20: -0.82 ± 0.09 vs. 1.13 ± 0.13 pps/mm Hg, P < 0.05). The results suggest that the baroreceptor dysfunction that controls the rSNA is an initial change in the obesity induced in high-fat-fed rats, which might be a predictor of sympathoexcitation and hypertension associated to obesity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257982     DOI: 10.1038/oby.2012.4

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  10 in total

Review 1.  Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.

Authors:  W Chen; S Leo; C Weng; X Yang; Y Wu; X Tang
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 2.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

3.  Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats.

Authors:  Shinji Kosaka; Nicolas Pelisch; Matlubur Rahman; Daisuke Nakano; Hirofumi Hitomi; Hiroyuki Kobori; Noriyasu Fukuoka; Hideki Kobara; Hirohito Mori; Tsutomu Masaki; Ludek Cervenka; Yasuo Matsumura; Hitoshi Houchi; Akira Nishiyama
Journal:  J Pharmacol Sci       Date:  2013-01-22       Impact factor: 3.337

4.  Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms.

Authors:  Jackie M Y How; Suhail A Wardak; Shaik I Ameer; Rachel A Davey; Daniela M Sartor
Journal:  J Physiol       Date:  2014-02-03       Impact factor: 5.182

5.  Blood Pressure Control at Rest and during Exercise in Obese Children and Adults.

Authors:  Konstantina Dipla; George P Nassis; Ioannis S Vrabas
Journal:  J Obes       Date:  2012-05-14

6.  Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension.

Authors:  Louise E Harris; David G Morgan; Nina Balthasar
Journal:  Physiol Rep       Date:  2014-03-20

7.  Importance of AT1 and AT2 receptors in the nucleus of the solitary tract in cardiovascular responses induced by a high-fat diet.

Authors:  Guilherme F Speretta; Prashant J Ruchaya; Maria A Delbin; Mariana R Melo; Hongwei Li; José V Menani; Colin Sumners; Eduardo Colombari; Mirian Bassi; Débora S A Colombari
Journal:  Hypertens Res       Date:  2019-01-10       Impact factor: 3.872

8.  Ablation of TRPV1 Abolishes Salicylate-Induced Sympathetic Activity Suppression and Exacerbates Salicylate-Induced Renal Dysfunction in Diet-Induced Obesity.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

9.  Cardiovascular changes in animal models of metabolic syndrome.

Authors:  Alexandre M Lehnen; Bruno Rodrigues; Maria Cláudia Irigoyen; Kátia De Angelis; Beatriz D'Agord Schaan
Journal:  J Diabetes Res       Date:  2013-03-14       Impact factor: 4.011

10.  Ablation of TRPV1 Elevates Nocturnal Blood Pressure in Western Diet-fed Mice.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Curr Hypertens Rev       Date:  2019
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.